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Kathryn B. Garber1,*Genetic Variation Predicts Mental Illness and
Creativity
The idea that creative genius and mental illness can go
hand-in-hand is not a new one, but exploring this link
from the point of view of overlapping common variation
is. Power et al. established a risk-scoring system for schizo-
phrenia and bipolar disorder by using markers identified in
multiple prior genome-wide association studies. They next
sought an association between these same risk scores and
creativity, defined by membership in national artistic
societies for endeavors such as dance and visual arts. An
association was detected between creativity and the schizo-
phrenia and bipolar polygenic risk scores, but not for those
of 20 non-psychiatric diseases, suggesting a potential over-
lapping neurological etiology for these phenotypes.
Power et al. (2015). Nat. Neurosci. 18, 953–955.
DOCK2 Immunodeficiency: From Gene to Therapy
Startingwith a collectionoffive individualswhohad severe,
early-onset bacterial and viral infections, Dobbs et al. used
next-generation sequencing to identify pathogenic vari-
ants inDOCK2 as the cause. Further characterizationof cells
from these individuals revealed that impairment ofDOCK2
function results in a variety of defective responses by T, B,
and natural killer cells and in impaired production of inter-
feron-a and interferon-g by peripheral-bloodmononuclear
cells. Given that this immunodeficiency results in reduced
T cell receptor excision circles, which are a marker of T cell
production, it will be detected by newborn screening, and
it can be cured via hematopoietic stem cell transplant if per-
formed early enough.
Dobbs et al. (2015). N. Engl. J. Med. 372, 2409–2422.
Ongoing Selection
The interplay between malaria and sickle cell disease is the
classic example of heterozygote advantage; on a popula-
tion level, the negative effects of sickle cell disease are
balanced by the advantage that trait heterozygosity pro-
vides against malarial infections. This relationship is often
presented in historical terms, so Elguero et al. used modern
data to explore whether the selective force is still at play in
Africa, a location where malaria and sickle cell disease
remain major public-health challenges. The researchers
collected nearly 4,000 blood samples from across the Re-
public of Gabon, where the prevalence of the sickle cell
trait has been reported to be as high as 1 in 4 individuals.1Department of Human Genetics, Emory University School of Medicine, Atlan
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The AmerUsing PCR for cytochrome b from Plasmodium to detect
evidence of the parasites, they found that, even today, an
association exists between the prevalence of Plasmodium
infections and the sickle cell trait. In fact, the selection
coefficient Elguero et al. calculated from their data is
almost identical to that calculated by Cavalli-Sforza and
Bodmer in 1971. Lest we think that we are above the con-
straints of evolution at this point in our history, this work
provides evidence to the contrary.
Elguero et al. (2015). Proc. Natl. Acad. Sci. USA 112: 7051–
7054.
Using Circulating Tumor DNA to Monitor Resistance
to Therapy
Therapeutic monoclonal antibodies to epidermal growth
factor receptor (EGFR) can be an effective treatment of
colorectal cancer, but mutations in signaling pathways
downstream of the receptor correlate with resistance to
this therapy. Even when optimal patients are selected for
therapy via tumor genetic testing, many do not respond,
and even in those who do, resistance can develop in
conjunction with mutations that subsequently arise in
the tumor. A lack of readily available tumor samples
from the same patient over time impedes our understand-
ing of the efficacy of these drugs, leading Siravegna et al.
to assess the use of circulating tumor DNA as a way to
monitor drug resistance in colorectal cancer patients who
receive anti-EGFR therapy. This strategy allowed them to
identifymutations likely to be responsible for primary resis-
tance to the therapy and others that corresponded to the
acquisition of drug resistance. Resistance mutations waned
in circulatingDNAwhen treatmentwith the antibodieswas
suspended, leading the tumors to again respond to the
antibodies when re-challenged. Beyond increasing our
understanding of the dynamic response of tumors to treat-
ment, monitoring relevant gene sequences in circulating
tumor DNA might be a useful way to guide therapeutic ap-
proaches to treating cancer.
Siravegna et al. (2015). Nat Med. 21, 795–801.
Reawakening
Endogenous retroviruses make up a good chunk of our
genome.As evidencedbypolymorphic insertions in thehu-
manpopulation, someof these inserted elements canmove
around, but they are generally thought of as dormant
genomic segments. HERVK, one of themost recent of theseta, GA 30322, USA
y of Human Genetics. All rights reserved.
ican Journal of Human Genetics 97, 197–198, August 6, 2015 197
retroviruses to make its way into humans, actually main-
tains open reading frames for its own retroviral proteins,
but in most cases, our cells keep it transcriptionally inacti-
vated. A major exception was just described by Grow
et al.,whodocumented reawakeningofHERVKduring early
embryogenesis. Beyond showing that viral-like particles are198 The American Journal of Human Genetics 97, 197–198, August 6present in blastocysts, they also found that the HERVK pro-
tein Rec triggers an innate antiviral response and that it
binds to cellular RNAs and modulates their ribosome occu-
pancy, suggesting that the retrovirus could influence early
development. Just how remains to be seen.
Grow et al. (2015). Nature 522, 221–225.This Month in Our Sister JournalsSelf-Reported versus Genetic Ancestry
Population structure is an important consideration in ge-
netic epidemiology studies. The simplest way to address it
is to ask research subjects about their ancestry and stratify
samples according to the answer. Alternatively, one can
use geneticmarkers to group subjects according to ancestry.
Howwell do these twomethods jibewith eachother? Banda
et al. addressed this questionbyusing a sampleofmore than
100,000 individuals assembled byKaiser Permanente in the
Genetic Epidemiology Research on Adult Health and Aging
cohort. Genetic ancestry based on SNP genotyping corre-
sponded well with self-reported race and ancestry, but ashas been demonstrated before, beingwithin the same racial
group doesn’t imply homogeneity; among African Ameri-
cans, for example, the proportion of African ancestry
ranged from approximately 10% to 100%. Increased recent
mixing between populations is reflected in the fact that
parent-child pairs were less likely to be concordant for
race than were sibling pairs and in the fact that there
was a correlation between self-reported mixed race and
lower age. This increased exogamy is likely to add to the
complexity of future genetic epidemiology studies.
Banda et al. (2015). Genetics. Published online June 19,
2015. http://dx.doi.org/10.1534/genetics.115.178616., 2015
